Poly(ADP-ribose)polymerase 2 is zinc-dependent enzyme and nucleosome reorganizer
Poly(ADP-ribose)polymerase 2 (PARP2) is a nuclear protein, DNA damage sensor and an emerging target for development of anti-cancer drugs. Previously it was discovered that PARP2 binds to nucleosomes; however, critical factors involved in this process remain unknown. We demonstrated that in the presence of Mg<sup>2+</sup> or Ca<sup>2+</sup> ions PARP2 forms complexes with a nucleosome containing different number of PARP2 molecules without altering conformation of nucleosomal DNA. In contrast, Zn<sup>2+</sup> ions directly interact with PARP2 inducing a local alteration of the secondary structure of the protein and PARP2-mediated, reversible structural reorganization of nucleosomes. WGR domain of PARP2 is the target for Zn<sup>2+</sup> ions since this domain contains two putative Zn<sup>2+-</sup>binding sites, binds Zn<sup>2+</sup> ions and alone drives Zn<sup>2+</sup>-mediated reorganization of nucleosomes. Auto(poly-ADP-ribosylation) activity of PARP2 is enhanced by Mg<sup>2+</sup> ions and modulated by Zn<sup>2+</sup> ions: suppressed or enhanced depending on the occupancy of two functionally different zinc binding sites. The data suggest that transient changes in concentration of cations can differentially modulate PARP2 activity, local chromatin structure and the DNA damage response.
Authors
- O. V. Geraskina
- Vasily M. Studitsky (ORCID: https://orcid.org/0000-0002-7389-7993)
- Alexey V. Feofanov (ORCID: https://orcid.org/0000-0002-1596-9506)
- М. П. Кирпичников (ORCID: https://orcid.org/0000-0001-8170-1607)
- Grigoriy A. Armeev (ORCID: https://orcid.org/0000-0001-9223-7010)
- Alexandra Saulina
- Natalya Maluchenko
- Elena Kotova
- Anna N. Korovina
Institutions
- Fox Chase Cancer Center (US)
- Lomonosov Moscow State University (RU)
- Institute of Bioorganic Chemistry (RU)
- Moscow State University (TJ)
Publication Details
- Journal
- Cellular and Molecular Life Sciences
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1007/s00018-025-05785-8
- Citations
- 2
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Foundation for the National Institutes of Health
- Russian Foundation for Fundamental Investigations
- Russian Science Foundation
- National Institutes of Health